Yamamoto, Y., Matsui, J., Matsushima, T., Obaishi, H., Miyazaki, K., Nakamura, K., Tohyama, O., Semba, T., Yamaguchi, A., Hoshi, S., Mimura, F., Haneda, T., Fukuda, Y., Kamata, J., Takahashi, K., Matsukura, M., Wakabayashi, T., Asada, M., Nomoto, K., Watanabe, T., Dezso, Z., Yoshimatsu, K., Funahashi, Y., & Tsuruoka, A. (2014). Lenvatinib, an angiogenesis inhibitor targeting VEGFR/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage. Vascular Cell, 6(1), 18. doi:10.1186/2045-824X-6-18